AU2056801A - Transforming growth factor alpha hiii - Google Patents

Transforming growth factor alpha hiii

Info

Publication number
AU2056801A
AU2056801A AU20568/01A AU2056801A AU2056801A AU 2056801 A AU2056801 A AU 2056801A AU 20568/01 A AU20568/01 A AU 20568/01A AU 2056801 A AU2056801 A AU 2056801A AU 2056801 A AU2056801 A AU 2056801A
Authority
AU
Australia
Prior art keywords
growth factor
transforming growth
factor alpha
alpha hiii
hiii
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU20568/01A
Inventor
Ying-Fei Wei
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of AU2056801A publication Critical patent/AU2056801A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/495—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU20568/01A 1999-12-02 2000-12-01 Transforming growth factor alpha hiii Abandoned AU2056801A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16838799P 1999-12-02 1999-12-02
US60168387 1999-12-02
PCT/US2000/032745 WO2001040251A1 (en) 1999-12-02 2000-12-01 Transforming growth factor alpha hiii

Publications (1)

Publication Number Publication Date
AU2056801A true AU2056801A (en) 2001-06-12

Family

ID=22611307

Family Applications (1)

Application Number Title Priority Date Filing Date
AU20568/01A Abandoned AU2056801A (en) 1999-12-02 2000-12-01 Transforming growth factor alpha hiii

Country Status (5)

Country Link
EP (1) EP1244686A4 (en)
JP (1) JP2003515326A (en)
AU (1) AU2056801A (en)
CA (1) CA2390839A1 (en)
WO (1) WO2001040251A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015034897A1 (en) * 2013-09-03 2015-03-12 Mayo Foundation For Medical Education And Research Reducing the risk of major adverse cardiac events

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0873360A4 (en) * 1996-01-04 2000-06-21 Human Genome Sciences Inc Transforming growth factor alpha hiii
AU9283298A (en) * 1997-10-08 1999-04-27 Protegene Inc. Human proteins having transmembrane domains and cdnas encoding these proteins

Also Published As

Publication number Publication date
EP1244686A1 (en) 2002-10-02
JP2003515326A (en) 2003-05-07
CA2390839A1 (en) 2001-06-07
EP1244686A4 (en) 2003-04-23
WO2001040251A1 (en) 2001-06-07

Similar Documents

Publication Publication Date Title
AU7059300A (en) Immediate provisional implant
AU7109500A (en) Liquefracture handpiece
AU7373100A (en) Liquefracture handpiece
AU5639900A (en) Shaped scalpel
AU7496800A (en) Liquefracture handpiece
AU1173201A (en) Skin-gripper
AU3924300A (en) Fibroblast growth factor-20
AUPR030900A0 (en) Growth factor complex
AU2678800A (en) Modified calycins
AU4694696A (en) Transforming growth factor alpha hiii
AU2950200A (en) Artificial reef
AU4596200A (en) Wheelchair
AU5003800A (en) Implant system
AU6001200A (en) Expression system
AU2056801A (en) Transforming growth factor alpha hiii
AU1901801A (en) Glucofuranoses
AU5440800A (en) Fibroblast growth factor 10
AU5268000A (en) Fibroblast growth factor 15
AU4851200A (en) Fibroblast growth factor 11
AU5527296A (en) Growth factor htter36
AU1891399A (en) Photomultiplier
AUPQ167799A0 (en) Growth factor
AU5019700A (en) Fibroblast growth factor 14
AU6951400A (en) Fibroblast growth factor 13
AU2139800A (en) Implant

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase